Skip to main content
. 2016 Aug 16;2016:8302179. doi: 10.1155/2016/8302179

Table 2.

Clinical presentation of hospitalized children with EV-D68.

Clinical presentation n (%)
Month of presentation (total n = 34)
 August 1 (3)
 September 5 (15)
 October 25 (74)
 November 3 (9)

Parent reported symptoms at presentation (total n = 34)
 Shortness of breath 28 (82)
 Cough 28 (82)
 Rhinorrhea/congestion 24 (71)
 Fever 21 (62)
 Wheeze 15 (44)
 Vomiting 11 (32)

Vital signs at presentation (total n = 34)
 Tachypnea 27 (79)
 Tachycardia 20 (59)
 Oxygen saturation <92% 20 (59)
 Fever ≥ 38°C 4 (12)

Auscultatory findings (total n = 34)
 Decreased air entry 30 (88)
 Wheeze 26 (76)
 Crackles 12 (35)
 Silent chest 9 (26)

PRAM score at presentation (total n = 22)
 0–3 (mild) 0 (0)
 4–7 (moderate) 6 (27)
 8–12 (severe) 16 (73)

Laboratory findings (total n = 23)
 Leukocytosis∗∗ 12 (52)
 Neutrophilia∗∗ 17 (74)
 Lymphopenia∗∗ 19 (83)

Copathogens identified on PCR testing of nasopharyngeal washings (total n = 26) 11 (42)

Chest X-ray findings (total n = 29)
 Normal chest X-ray 4 (14)
 Minor patchy changes 6 (21)
 Major patchy changes 6 (21)
 Lobar changes 1 (3)
 Peribronchial thickening 11 (38)
 Hyperinflation 9 (31)

Vital sign parameters were defined according to norms for age as per the Hospital of Sick Children's Handbook of Pediatrics [15].

∗∗As defined by BCCH's laboratory reference values for age.